An organization of physicians and others concerned about the politicization of healthcare is praising the “doctors around the world” who are “speaking up” about the “significant” risks associated with childhood medical gender transition and the lack of evidence supporting the claim that transgender hormone drugs reduce suicide risk.
Dr. Stanley Goldfarb, chairman of Do No Harm wrote Monday in an email to subscribers of the recent “game-changing” letter to the editors, published in the Wall Street Journal by 21 clinicians and researchers from South Africa, the UK, Sweden, Norway, Belgium, France, Switzerland, and the United States, that challenges the Endocrine Society’s latest statements on what radical transgender activists call “gender-affirming care.”
A poll published Thursday found 72.7 percent of American voters say they are not likely to vote for candidates running in the midterm elections who support gender transition procedures, such as puberty blockers, cross-sex hormones, and surgeries, for minors.
The survey, sponsored by Convention of States Action and conducted by The Trafalgar Group, found 63.3 percent of 1,080 likely general election voters say they are not likely to vote for a candidate who supports gender transition medical procedures for minors, and 9.4 percent say somewhat less likely – a total of 72.7 percent who say they are not likely to vote for candidates with those views.
The Florida Board of Medicine has voted to ban puberty blockers, cross-sex hormones, and surgeries such as double mastectomies and castrations – what LGBTQ activists call “gender-affirming care” – for children under the age of 18 in the state.
The move to prohibit the life-altering hormones and surgeries for the treatment of gender dysphoria in children and teens makes the Florida medical board the first in the nation to pursue such a rule, NBC News reported Saturday.